Clostridium Difficile (C. Difficile) Completed Phase 2 Trials for Bifidobacterium longum (DB19248)

Also known as: C-Difficile / Difficile / C. Difficile

Indication	Status	Phase
DBCOND0120840 (Clostridium Difficile (C. Difficile))	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01782755	Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial	Prevention	Bifidobacterium longum (DB19248) Lactobacillus acidophilus (DB15823)